These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26695419)

  • 1. New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review.
    Dhakal P; Pathak R; Giri S; Murthy GS; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):87-91. PubMed ID: 26695419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel oral anticoagulants for heparin-induced thrombocytopenia.
    Skelley JW; Kyle JA; Roberts RA
    J Thromb Thrombolysis; 2016 Aug; 42(2):172-8. PubMed ID: 27102287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapy options in heparin-induced thrombocytopenia.
    Chaudhary RK; Khanal N; Giri S; Pathak R; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2014; 12(1):50-8. PubMed ID: 25374012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.
    Tran PN; Tran MH
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):201-209. PubMed ID: 28301915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
    Warkentin TE; Pai M; Linkins LA
    Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From heparin to apixaban: anticoagulants cut both ways?].
    Hartung K; Meyer F; Bock F; Isermann B
    Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-acting oral anticoagulants as emerging treatment options for heparin-induced thrombocytopenia.
    Miyares MA; Davis KA
    Ann Pharmacother; 2015 Jun; 49(6):735-9. PubMed ID: 25855702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
    Davis KA; Davis DO
    Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review.
    Sadowski C; Reinert JP
    Am J Health Syst Pharm; 2024 Sep; 81(19):e584-e593. PubMed ID: 38651828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
    Wang Y; Zhang K; Yin L; Fu G; Liu Z
    Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 18. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
    Efird LE; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
    PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review.
    Bhatt VR; Dahal S; Verma V; Shukla P; Khanal N; Pathak R; Giri S
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):82-6. PubMed ID: 26362274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.